Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 18 04:00PM ET
24.78
Dollar change
-0.52
Percentage change
-2.06
%
IndexRUT P/E- EPS (ttm)-2.73 Insider Own12.33% Shs Outstand51.16M Perf Week-10.54%
Market Cap1.27B Forward P/E- EPS next Y-3.40 Insider Trans-11.13% Shs Float44.85M Perf Month-22.61%
Income-95.93M PEG- EPS next Q-0.76 Inst Own72.92% Short Float20.78% Perf Quarter45.34%
Sales21.99M P/S57.65 EPS this Y-13.58% Inst Trans0.28% Short Ratio7.65 Perf Half Y153.89%
Book/sh7.72 P/B3.21 EPS next Y-16.10% ROA-29.90% Short Interest9.32M Perf Year42.74%
Cash/sh6.25 P/C3.97 EPS next 5Y- ROE-33.00% 52W Range9.44 - 36.25 Perf YTD22.31%
Dividend Est.- P/FCF- EPS past 5Y-46.35% ROI-28.05% 52W High-31.64% Beta2.91
Dividend TTM- Quick Ratio18.07 Sales past 5Y111.29% Gross Margin74.42% 52W Low162.50% ATR (14)1.82
Dividend Ex-Date- Current Ratio18.07 EPS Y/Y TTM17.81% Oper. Margin-477.24% RSI (14)35.89 Volatility6.26% 6.24%
Employees147 Debt/Eq0.05 Sales Y/Y TTM1014.45% Profit Margin-436.30% Recom1.09 Target Price52.20
Option/ShortYes / Yes LT Debt/Eq0.04 EPS Q/Q69.41% Payout- Rel Volume0.34 Prev Close25.30
Sales Surprise-100.75% EPS Surprise4.96% Sales Q/Q3940.80% EarningsFeb 29 AMC Avg Volume1.22M Price24.78
SMA20-16.50% SMA50-14.71% SMA20030.55% Trades Volume417,554 Change-2.06%
Date Action Analyst Rating Change Price Target Change
Apr-15-24Initiated Barclays Overweight $459
Apr-15-24Initiated Barclays Overweight $45
Feb-07-24Resumed Goldman Buy $81
Oct-26-23Initiated RBC Capital Mkts Outperform $25
Oct-24-23Initiated Cantor Fitzgerald Overweight $32
Oct-18-23Upgrade Leerink Partners Market Perform → Outperform $24
Jul-05-23Initiated Chardan Capital Markets Buy $30
Jan-30-23Initiated BMO Capital Markets Outperform $50
Nov-18-22Initiated H.C. Wainwright Buy $36
Nov-15-22Upgrade Goldman Neutral → Buy $12 → $68
Apr-04-24 01:30AM
Mar-29-24 07:01PM
Mar-28-24 08:00AM
Mar-04-24 08:00AM
Mar-02-24 04:32AM
06:05PM Loading…
Feb-29-24 06:05PM
04:05PM
Feb-12-24 08:00AM
Feb-08-24 03:05AM
Feb-06-24 11:27PM
Feb-05-24 04:05PM
02:50PM
12:36PM
Feb-03-24 05:00PM
Jan-29-24 08:00AM
10:04PM Loading…
Jan-25-24 10:04PM
Jan-23-24 08:00AM
Jan-19-24 12:00PM
Jan-11-24 10:00AM
Jan-09-24 05:02AM
Jan-06-24 05:02AM
05:02AM
Jan-04-24 08:00AM
Jan-03-24 08:01AM
Dec-21-23 08:00AM
Dec-04-23 08:00AM
Nov-15-23 08:00AM
Nov-09-23 04:19PM
Nov-01-23 04:00PM
Oct-30-23 08:00AM
09:56AM Loading…
Oct-26-23 09:56AM
Oct-25-23 08:00AM
Oct-23-23 08:00AM
Sep-12-23 04:05PM
Sep-07-23 04:05PM
08:00AM
Aug-09-23 06:15PM
04:05PM
08:22AM
Jul-29-23 12:00PM
Jul-17-23 04:05PM
Jul-10-23 07:30PM
Jun-08-23 09:53AM
Jun-07-23 04:10PM
Jun-01-23 08:00AM
May-24-23 08:00AM
May-13-23 08:27AM
May-12-23 06:02PM
06:02PM
May-11-23 08:00AM
May-10-23 05:55PM
04:05PM
May-09-23 04:05PM
08:25AM
May-08-23 04:05PM
06:27AM
May-04-23 09:04PM
04:08PM
Apr-27-23 04:29PM
07:00AM
Apr-24-23 08:00AM
08:00AM
Apr-14-23 04:23AM
Apr-13-23 08:00AM
Apr-12-23 08:21AM
Mar-24-23 06:30AM
Mar-22-23 08:09AM
Mar-15-23 05:45PM
04:05PM
Mar-02-23 05:41AM
Feb-23-23 11:33AM
Feb-22-23 04:05PM
Feb-16-23 04:05PM
Feb-08-23 04:05PM
Feb-02-23 04:05PM
Jan-30-23 12:54PM
Jan-09-23 09:00AM
Dec-01-22 08:26PM
Nov-21-22 04:05PM
Nov-20-22 05:39AM
Nov-17-22 10:36AM
Nov-14-22 02:07PM
07:30AM
Nov-10-22 04:05PM
05:08AM
Nov-09-22 04:05PM
Nov-03-22 09:45AM
06:30AM
Oct-26-22 04:05PM
Sep-27-22 04:10PM
Sep-23-22 06:02AM
Sep-20-22 04:15PM
Aug-12-22 11:20AM
Aug-11-22 05:15PM
04:03PM
Jun-28-22 04:23PM
Jun-02-22 04:02PM
May-14-22 08:19AM
May-12-22 05:35PM
04:01PM
4D Molecular Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of unlocking the full potential of genetic medicines to treat large market diseases in ophthalmology and pulmonology. The firm also offers product candidates focused on large market ophthalmology, pulmonology, and cardiology. The company was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bizily ScottChief Legal OfficerApr 01 '24Option Exercise12.548,153102,2249,890Apr 03 07:18 PM
Bizily ScottChief Legal OfficerApr 01 '24Sale31.788,153259,1021,737Apr 03 07:18 PM
Bizily ScottChief Legal OfficerMar 27 '24Option Exercise25.985,833151,5417,570Mar 29 04:52 PM
Bizily ScottChief Legal OfficerMar 27 '24Sale35.045,833204,4101,737Mar 29 04:52 PM
Bizily ScottChief Legal OfficerMar 18 '24Option Exercise7.601,75013,2953,487Mar 20 04:40 PM
Bizily ScottChief Legal OfficerMar 18 '24Sale31.271,75054,7221,737Mar 20 04:40 PM
Bizily ScottChief Legal OfficerFeb 27 '24Option Exercise20.241,90938,6383,646Feb 29 06:01 PM
Bizily ScottChief Legal OfficerFeb 27 '24Sale30.001,90957,2701,737Feb 29 06:01 PM
Bizily ScottChief Legal OfficerFeb 16 '24Option Exercise7.601,75013,2953,487Feb 21 05:41 PM
Bizily ScottChief Legal OfficerFeb 16 '24Sale27.671,75048,4221,737Feb 21 05:41 PM
Bizily ScottChief Legal OfficerFeb 08 '24Option Exercise10.186,24463,5864,653Feb 12 09:04 PM
Kirn DavidChief Executive OfficerFeb 08 '24Sale27.1392,0012,495,8221,059,153Feb 12 08:22 PM
Bizily ScottChief Legal OfficerFeb 08 '24Sale27.506,244171,7101,737Feb 12 09:04 PM
Kim Robert YoungChief Medical OfficerFeb 05 '24Option Exercise15.2924,000366,84013,595Feb 07 08:32 PM
Kim Robert YoungChief Medical OfficerFeb 05 '24Sale30.0524,552737,7881,043Feb 07 08:32 PM
Kirn DavidChief Executive OfficerJan 23 '24Sale18.415,696104,8511,151,154Jan 25 04:59 PM
Kirn DavidChief Executive OfficerJan 05 '24Sale19.5728,237552,4781,156,850Jan 08 04:19 PM
VIKING GLOBAL INVESTORS LP10% OwnerJan 04 '24Sale19.53540,00010,546,2004,247,914Jan 05 05:44 PM
Kirn DavidChief Executive OfficerJan 04 '24Sale20.3140,732827,2021,185,087Jan 08 04:19 PM
Kirn DavidChief Executive OfficerDec 18 '23Sale18.134,70285,2431,225,819Jan 08 04:19 PM
Kirn DavidChief Executive OfficerDec 15 '23Sale17.2728,632494,4321,230,521Jan 08 04:19 PM
Bizily ScottChief Legal and HR OfficerJun 08 '23Option Exercise8.043,75030,1505,487Jun 12 06:23 PM
Bizily ScottChief Legal and HR OfficerJun 08 '23Sale20.853,75078,1881,737Jun 12 06:23 PM
Bizily ScottChief Legal and HR OfficerJun 01 '23Option Exercise6.491,87512,1693,984Jun 06 07:23 PM
Bizily ScottChief Legal and HR OfficerJun 01 '23Sale18.312,24741,1431,737Jun 06 07:23 PM
Moretti August JChief Financial OfficerMay 15 '23Option Exercise9.413,00028,23011,045May 16 08:52 PM
VIKING GLOBAL INVESTORS LP10% OwnerMay 09 '23Buy16.00850,00013,600,0004,787,914May 11 05:50 PM
Chacko JacobDirectorApr 21 '23Option Exercise9.415,00047,0505,000Apr 25 06:43 PM
Bizily ScottChief Legal and HR OfficerApr 21 '23Option Exercise8.043,75030,1505,859Apr 25 06:44 PM
Chacko JacobDirectorApr 21 '23Sale20.055,000100,2700Apr 25 06:43 PM
Bizily ScottChief Legal and HR OfficerApr 21 '23Sale20.003,75075,0002,109Apr 25 06:44 PM